Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVEAL-CKD: A Retrospective, Multinational Observational Study to Determine the Prevalence and Consequences of Undiagnosed Chronic Kidney Disease

NCT04847531 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04847531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04847531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVEAL-CKD: A Retrospective, Multinational Observational Study to Determine the Prevalence and Consequences of Undiagnosed Chronic Kidney Disease
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 15, 2020
Completion date
November 13, 2023
Enrollment
1,006,361 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease